$44.21
-0.02-0.05%
Last update: 3:28 PM
15 minutes delayed
Comments
Loading...
Sector
Healthcare
Region
US
AUM
178.36M
Fund Score
SPDR S&P Pharmaceuticals ETF (ARCA:XPH) Quotes, Forecast and News Summary
SPDR S&P Pharmaceuticals ETF (ARCA: XPH) stock price, news, charts, stock research, profile.
| Open | $44.39 |
| High | $44.49 |
| 52 Wk High | $45.62 |
| AUM | 178.36M |
| Dividend | $0.62 |
| Ex-Div Date | Jun 24, 2024 |
| Volume | 9.04K |
| Market Cap | $77.80B |
| Mgmt Fee | 0.35% |
| P/E Ratio | 16.08 |
| Prev. Close | $44.23 |
| Low | $44.21 |
| 52 Wk Low | $34.67 |
| Shares Out | 4.85M |
| Yield | 1.48% |
| Div. Freq | Quarterly |
| Avg. Volume Daily | 50.77K |
| Beta | 0.76 |
| Avg. Expense Ratio | 0.35% |
| P/B Ratio | - |
Recent News
FAQ
How do I buy SPDR S&P Pharmaceuticals ETF (XPH) stock?
You can purchase shares of SPDR S&P Pharmaceuticals ETF (ARCA:XPH) through any online brokerage.
Who are SPDR S&P Pharmaceuticals ETF (XPH) competitors?
There are no as such competitors for SPDR S&P Pharmaceuticals ETF.
What is the forecast, or price target, for SPDR S&P Pharmaceuticals ETF (XPH) stock?
There is no analysis for SPDR S&P Pharmaceuticals ETF to provide a consensus price target.
What is the current price for SPDR S&P Pharmaceuticals ETF (XPH)?
The stock price for SPDR S&P Pharmaceuticals ETF (ARCA: XPH) is $44.21 last updated September 16, 2024 at 3:28 PM EDT.
Does SPDR S&P Pharmaceuticals ETF (XPH) pay a dividend?
A quarterly cash dividend of 0.05 per share of Class A Common Stock. The quarterly cash dividend was payable on September 27, 2018 to stockholders of record on September 24, 2018.
When is SPDR S&P Pharmaceuticals ETF (ARCA:XPH) reporting earnings?
SPDR S&P Pharmaceuticals ETF does not have any upcoming earnings scheduled.
Is SPDR S&P Pharmaceuticals ETF (XPH) going to split?
There is no upcoming split for SPDR S&P Pharmaceuticals ETF.
ETF Details
| Sector | Healthcare |
| Category | Mid Performer-Mid Growth |
| Investment Style | Mid Cap Blend |
| Fund Inception | Jun 19, 2006 |
| Managers | Keith Richardson Karl A. Schneider |
| Definition | Most of the stocks in this Equity Fund have average financial performance and average growth potential |
Investment Policy
In seeking to track the performance of the S&P Pharmaceuticals Select Industry Index (the index), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the pharmaceuticals segment of the S&P Total Market Index (S&P TMI).